Journal article
Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer
- Abstract:
-
Pancreatic cancer remains one of the most lethal forms of cancer with a 10-year survival of <1%. With little improvement in survival rates observed in the past 40 years, there is a significant need for new treatments or more effective strategies to deliver existing treatments. The antimetabolite gemcitabine (Gem) is the most widely used form of chemotherapy for pancreatic cancer treatment, but is known to produce significant side effects when administered systemically. We have previously d...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 489.5KB)
-
- Publisher copy:
- 10.1016/j.jconrel.2018.04.018
Authors
Funding
Institution of Engineering and Technology
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Journal of Controlled Release Journal website
- Volume:
- 279
- Pages:
- 8-16
- Publication date:
- 2018-04-11
- Acceptance date:
- 2018-04-09
- DOI:
- ISSN:
-
0168-3659
- Pmid:
-
29653222
- Source identifiers:
-
836611
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:836611
- UUID:
-
uuid:89ab3174-61ab-42fa-9901-b3559b6183f0
- Local pid:
- pubs:836611
- Deposit date:
- 2018-05-31
Terms of use
- Copyright holder:
- Elsevier BV
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 Elsevier B.V. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/j.jconrel.2018.04.018
If you are the owner of this record, you can report an update to it here: Report update to this record